Researchers with the University of Iowa Institute for Clinical and Translational Science (ICTS) have launched a three-part project to improve screening and diagnosis of high blood pressure (hypertension) in postpartum women living in rural areas, with the long-term goal of improving treatment of this dangerous condition in this population.

Muscular dystrophy refers to a group of inherited conditions that affect muscle structure and function. It causes progressive muscle weakness, reduced mobility, a shortened lifespan, and, in some cases, severe cardiac and respiratory complications and neurological impairment.  There are many different types of muscular dystrophy, which are caused by various gene mutations that disrupt the…

Kevin P. Campbell, PhD, UI professor and internationally recognized researcher in the field of muscular dystrophy, has been named the 2026 winner of the August M. Watanabe Prize in Translational Research.

Four University of Iowa faculty members have been selected as recipients of the Iowa Mid-Career Faculty Scholar Awards for 2026. Among them is Mary Weber, PhD, associate professor in the Department of Microbiology and Immunology in the Carver College of Medicine.

Returning to Epworth and Winterset, two University of Iowa medical students reflect on the mentors, classrooms, and moments that first sparked their path to medicine.

Four University of Iowa faculty members are recipients of the 2026 President and Provost Award for Teaching Excellence, recognizing their exceptional and sustained contributions to student learning and success.

The Iowa Board of Regents will recognize six outstanding University of Iowa faculty members for their extraordinary contributions and sustained record of distinction in teaching, scholarship, and service.

An existing drug currently used to treat glaucoma, altitude sickness, and seizures may also have potential for preventing relapse in opioid use disorder, according to a new study by researchers at University of Iowa Health Care. The UI researchers led by John Wemmie, MD, PhD, focused on the drug known as acetazolamide (AZD) because it blocks the activity of a brain enzyme called carbonic…

Michelle Howard, PhD, has always been interested in pediatric cancers, but she credits her patients, not her profession, for pushing her and her research team toward the next innovative solution.

Tyler Draayer knew he could count on the University of Iowa to prepare him for a successful medical career.